People: AEterna Zentaris, Inc. (AEZS.O)
0.82USD
9 Feb 2010
$0.00 (+0.00%)
$0.82
--
$0.83
$0.81
70,900
188,761
$3.25
$0.60
Ernst, Juergen
Brief Biography
Mr. Juergen Ernst is Executive Chairman of AEterna Zentaris Inc., since September 1, 2008, after having served as Chairman of the Board from August 13, 2007 until April 10, 2008 and as Interim President and Chief Executive Officer from April 11, 2008 until August 31, 2008. He has served as a director on Board since 2005. A seasoned executive with more than 20 years of pharmaceutical industry expertise mainly in the field of corporate development and pharmaceutical product marketing, Mr. Ernst was worldwide General Manager, Pharmaceutical Sector of Solvay S.A., before retiring in 2004. He is now a member of the Board of Directors of Solvay S.A.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 335,427 | -- | 179,209 | 514,636 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Ernst, Juergen | 514,636 |
| Engel, Jurgen | 1,198,440 |
| Turpin, Dennis | 443,132 |
| Pelliccione, Nicholas | 401,865 |
| Blake, Paul | 511,288 |
| Seeber, Matthias | 496,481 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
